Skip to content
Back

Cancer – Physical activity has been shown to reduce the length of hospital stay in cancer patients

Reduce the length of hospital stay

Evidence summary

Two meta-analyses of studies of aerobic exercise programmes in lung cancer patients reported shorter hospital stays in the exercise groups (4-5). A prospective, non-randomised controlled clinical trial of physical activity prior to radical prostatectomy (6) and a systematic review of physical prehabilitation in surgery for colorectal cancer (2) however found no significant difference in hospital stay. The quality of studies in older patients undergoing colorectal surgery is poor.

Quality of evidence

Low quality

Strength of recommendation

Weak – on the basis of existing evidence and expert clinical opinion, some cancer patients may be expected to have improvements in length of hospital stay with pre-surgical physical activity.

Conclusion

Meta-analyses of studies in lung cancer have reported promising results with reduced length of hospital stay post-surgery, however there is a need for further high-quality studies for all cancer groups.

References

1. Singh F et al. A systematic review of pre-surgical exercise intervention studies with cancer patients. Surg Oncol.2013 Jun;22(2):92-104

2.Bruns ER et al. The effects of physical prehabilitation in elderly patients undergoing colorectal surgery: a systematic review. Colorectal Dis.2016 Aug;18(8):O267

3.Hijazi Y et al. A systematic review of prehabilitation programs in abdominal cancer surgery. Int J Surg.2017 Mar;39:156-162

4.Cavalheri V et al. Preoperative exercise training for patients with non-small cell lung cancer. Cochrane Database Syst Rev.2017 Jun 7;6:CD012020

5.Garcia R et al. Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg.2016 Sep;23(3):486-97

6.Angenete E et al. Physical activity before radical prostatectomy reduces sick leave after surgery – results from a prospective, non-randomized controlled clinical trial (LAPPRO). BMC Urol. 2016; 16: 50